Abu Dhabi Funding Authority (ADIA) is taking a big minority stake in Hologic Inc. The Marlborough, Massachusetts-based firm is a worldwide chief in ladies’s well being, devoted to creating revolutionary medical applied sciences that successfully detect, diagnose and deal with well being situations and lift the usual of care around the globe.
ADIA is a part of the consortium that’s taking the corporate personal. It contains funds managed by Blackstone and TPG. The transaction is valued at as much as US$79 per share, representing an enterprise worth of as much as US$18.3 billion.
The transaction is anticipated to shut within the first half of calendar yr 2026, topic to the approval of Hologic’s stockholders, different regulatory approvals and satisfaction of sure customary closing situations. It has been unanimously authorised by the Hologic Board of Administrators, which has really helpful that stockholders vote their shares to approve the transaction and undertake the merger settlement.
Hologic delivered full-year income of US$4.03 billion for 2024, and issued steering of accelerating it to US$4.15 billion to US$4.2 billion for FY2025. Following the announcement of the transaction, the corporate plans to report its monetary outcomes for the fourth quarter of fiscal 2025 on November 3. Nevertheless, it doesn’t intend to supply monetary steering for fiscal 2026 within the announcement.
Hologic to go personal post-deal
Blackstone and TPG will purchase all excellent Hologic shares for US$76 per share in money, plus a non-tradable contingent worth proper (CVR) to obtain as much as US$3 per share in two funds of as much as US$1.50 every. The non-tradable CVR can be issued to Hologic stockholders at closing and paid following achievement of sure international income targets for Hologic’s Breast Well being enterprise in 2026 and 2027.
The mixture buy value represents a premium of roughly 46 per cent to Hologic’s closing value on Might 23, 2025, the final full buying and selling day previous to media reviews concerning a doable transaction involving the corporate.
Upon completion of the transaction, Hologic’s frequent inventory shall be delisted from the Nasdaq inventory market. The corporate will preserve its headquarters in Marlborough, and can proceed to function beneath the Hologic title and model.
Stephen P MacMillan, Hologic’s Chairman, President and Chief Government Officer, commented: “At this time marks an thrilling new chapter for Hologic as we be part of forces with the distinctive groups at Blackstone and TPG. Their assets, experience and dedication to ladies’s well being, will assist speed up our progress and improve our capability to ship essential medical applied sciences to clients and their sufferers around the globe.
“This transaction delivers rapid and compelling worth to Hologic stockholders, reflecting the dedication of our workers whose onerous work has made this milestone doable.”
Ram Jagannath, a Senior Managing Director at Blackstone, added: “Hologic is an excellent international chief in advancing ladies’s well being, with a longstanding popularity for groundbreaking and high-quality medical machine and diagnostic merchandise.
“We now have carefully adopted the corporate for a few years and lengthy admired the optimistic influence its life-changing applied sciences have had for thousands and thousands of sufferers worldwide.”
